Biopharmaceutics : (Record no. 89663)

000 -LEADER
fixed length control field 05075cam a2200541Ii 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250310101824.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250310b ||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119678281
Qualifying information (cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119678366
Qualifying information (electronic bk. : oBook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119678366
Qualifying information (electronic bk. : oBook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119678373
Qualifying information (epub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119678374
Qualifying information (epub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781119678274
Qualifying information (adobe pdf)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1119678277
Qualifying information (adobe pdf)
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/9781119678366
Source of number or code doi
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1284917134
Canceled/invalid control number (OCoLC)1284919037
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.5
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 35
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7
Edition number 23
130 0# - MAIN ENTRY--UNIFORM TITLE
Uniform title Biopharmaceutics (Batchelor)
245 10 - TITLE STATEMENT
Title Biopharmaceutics :
Remainder of title from fundamentals to industrial practice /
Statement of responsibility, etc edited by Hannah Batchelor.
250 ## - EDITION STATEMENT
Edition statement First edition.
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Chichester, UK ;
-- Hoboken, NJ :
Name of publisher, distributor, etc John Wiley & Sons,
Date of publication, distribution, etc 2022.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent.
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia.
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier.
490 1# - SERIES STATEMENT
Series statement Advances in pharmaceutical technology.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Formatted contents note An introduction to biopharmaceutics / Hannah Batchelor -- Basic pharmacokinetics / Hamid A. Merchant -- Introduction to biopharmaceutics measures / Hannah Batchelor and Pavel Gershkovich -- Solubility / Hannah Batchelor -- Permeability / Chris Roe and Vanessa Zann -- Dissolution / Hannah Batchelor and James Butler -- Biopharmaceutics to inform candidate drug selection and optimisation / Linette Ruston -- Biopharmaceutics tools for rational formulation design / Panagiota Zarmpi, Mark McAllister, James Butler, and Nikoletta Fotaki -- Biopharmaceutic classification system / Hannah Batchelor and Talia Flanagan -- Regulatory biopharmaceutics / Shanoo Budhdeo, Paul A. Dickinson, and Talia Flanagan -- Impact of anatomy and physiology / Francesca K. H. Gavins, Christine M. Madla, Sarah J. Trenfield, Laura E. McCoubrey, Abdul W. Basit, and Mark McAllister -- Integrating biopharmaceutics to predict oral absorption using PBPK modelling / Konstantinos Stamatopoulos -- Special populations / Christine M. Madla, Francesca K. H. Gavins, Sarah J. Trenfield, and Abdul W. Basit -- Inhalation biopharmaceutics / Precious Akhuemokhan, Magda Swedrowska and Ben Forbes -- Biopharmaceutics of injectable formulations / Wang Wang Lee and Claire M. Patterson -- Biopharmaceutics of topical and transdermal formulations / Hannah Batchelor -- Impact of the microbiome on oral biopharmaceutics / Laura E. McCoubrey, Hannah Batchelor, Abdul W. Basit, Simon Gaisford, and Mine Orlu.
520 ## - SUMMARY, ETC.
Summary, etc "This book arose as a result of this mission where the members of the focus group recognised the need to provide training for those wanting to better understand biopharmaceutics and serves as a handbook to introduce the tools used within biopharmaceutics as applied to drug development. The first six chapters cover the basics of biopharmaceutics and provide the context that underpins the later chapters. Chapters 7 and 8 specifically deal with how biopharmaceutics is integrated into product development within the pharmaceutical industry. Chapters 9 and 10 provide information on the regulatory aspects of biopharmaceutics. Chapter 11 highlights the impact of physiology and anatomy and how this can affect the rate and extent of drug absorption. Physiologically based modelling is a valuable asset in the biopharmaceutics toolkit, and this is introduced in Chapter 12. Chapter 13 provides information on a more advanced topic, the application of biopharmaceutics to special populations. Although oral administration remains the mainstay of drug therapy, it is not the exclusive route of administration, Chapters 14-16 cover alternative routes of administration. A newly emerging topic that considers the impact of the microbiome on the rate and extent of drug absorption is included as the final chapter in this book"--
Assigning source Provided by publisher.
545 0# - BIOGRAPHICAL OR HISTORICAL DATA
Biographical or historical note About the Author<br/>Edited by<br/><br/>Hannah Batchelor, Strathclyde Institute of Pharmacy and Biomedical Sciences.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biopharmaceutics.
Authority record control number http://id.loc.gov/authorities/subjects/sh85014252.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Design.
Authority record control number http://id.loc.gov/authorities/subjects/sh88001157.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biopharmaceutics
General subdivision methods.
Authority record control number https://id.nlm.nih.gov/mesh/D001702Q000379.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Design.
Authority record control number https://id.nlm.nih.gov/mesh/D015195.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biopharmaceutics.
Authority record control number https://id.nlm.nih.gov/mesh/D001702.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Batchelor, Hannah,
Authority record control number http://id.loc.gov/authorities/names/n2021183332
Relator term editor.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Advances in pharmaceutical technology.
Authority record control number http://id.loc.gov/authorities/names/n2013182303.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://onlinelibrary.wiley.com/doi/book/10.1002/9781119678366
Link text Full text available at Wiley Online Library Click here to view
942 ## - ADDED ENTRY ELEMENTS
Source of classification or shelving scheme
Item type EBOOK
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Date acquired Source of acquisition Inventory number Full call number Barcode Date last seen Price effective from Item type
          COLLEGE LIBRARY COLLEGE LIBRARY 2025-03-10 ALBASA 51286 615.7 B5241 2022 CL-51286 2025-03-10 2025-03-10 EBOOK